KALI SULPH

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: KALI SULPH
Generic name: POTASSIUM SULFATE
Manufacturer: Hyland's Inc.
Product type: HUMAN OTC DRUG
SPL set ID: c00e31d8-76df-47b1-bafd-36d088395522
SPL ID: f0330ffb-503d-2671-e053-2995a90a8218
Version: 4
Effective date: 2022-12-19
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:23:29

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		KALI SULPH	openfda.brand_name
generic name		POTASSIUM SULFATE	openfda.generic_name
manufacturer name		Hyland's Inc.	openfda.manufacturer_name
ndc	package	54973-5230-2	openfda.package_ndc
ndc	package	54973-5230-1	openfda.package_ndc
ndc	product	54973-5230	openfda.product_ndc
ndc11	package	54973523002	derived:openfda.package_ndc
ndc11	package	54973523001	derived:openfda.package_ndc
spl id		f0330ffb-503d-2671-e053-2995a90a8218	id
spl set id		c00e31d8-76df-47b1-bafd-36d088395522	set_id
unii		1K573LC5TV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use if imprinted cap band is broken or missing. If symptoms persist for more than seven days or worsen, contact a licensed health care provider. Discontinue use if symptoms are accompanied by a high fever (over 101° F). If you are pregnant or nursing, seek the advice of a licensed health care provider before using this product. Keep this and all medications out of the reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.